Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Jul 2024)

Checkpoint Kinase 1 Stimulates Endogenous Cardiomyocyte Renewal and Cardiac Repair by Binding to Pyruvate Kinase Isoform M2 C‐Domain and Activating Cardiac Metabolic Reprogramming in a Porcine Model of Myocardial Ischemia/Reperfusion Injury

  • Tian‐Wen Wei,
  • Tian‐Kai Shan,
  • Hao Wang,
  • Jia‐Wen Chen,
  • Tong‐Tong Yang,
  • Liu‐Hua Zhou,
  • Di Zhao,
  • Jia‐Teng Sun,
  • Si‐Bo Wang,
  • Ling‐Feng Gu,
  • Chong Du,
  • Qi‐Qi Jiang,
  • Rui Sun,
  • Qi‐Ming Wang,
  • Xiang‐Qing Kong,
  • Xiao‐Hu Lu,
  • Hao‐Liang Sun,
  • Yi Xu,
  • Li‐Ping Xie,
  • Ai‐Hua Gu,
  • Feng Chen,
  • Yong Ji,
  • Xue‐Jiang Guo,
  • Lian‐Sheng Wang

DOI
https://doi.org/10.1161/JAHA.124.034805
Journal volume & issue
Vol. 13, no. 13

Abstract

Read online

Background The regenerative capacity of the adult mammalian hearts is limited. Numerous studies have explored mechanisms of adult cardiomyocyte cell‐cycle withdrawal. This translational study evaluated the effects and underlying mechanism of rhCHK1 (recombinant human checkpoint kinase 1) on the survival and proliferation of cardiomyocyte and myocardial repair after ischemia/reperfusion injury in swine. Methods and Results Intramyocardial injection of rhCHK1 protein (1 mg/kg) encapsulated in hydrogel stimulated cardiomyocyte proliferation and reduced cardiac inflammation response at 3 days after ischemia/reperfusion injury, improved cardiac function and attenuated ventricular remodeling, and reduced the infarct area at 28 days after ischemia/reperfusion injury. Mechanistically, multiomics sequencing analysis demonstrated enrichment of glycolysis and mTOR (mammalian target of rapamycin) pathways after rhCHK1 treatment. Co‐Immunoprecipitation (Co‐IP) experiments and protein docking prediction showed that CHK1 (checkpoint kinase 1) directly bound to and activated the Serine 37 (S37) and Tyrosine 105 (Y105) sites of PKM2 (pyruvate kinase isoform M2) to promote metabolic reprogramming. We further constructed plasmids that knocked out different CHK1 and PKM2 amino acid domains and transfected them into Human Embryonic Kidney 293T (HEK293T) cells for CO‐IP experiments. Results showed that the 1–265 domain of CHK1 directly binds to the 157–400 amino acids of PKM2. Furthermore, hiPSC‐CM (human iPS cell‐derived cardiomyocyte) in vitro and in vivo experiments both demonstrated that CHK1 stimulated cardiomyocytes renewal and cardiac repair by activating PKM2 C‐domain‐mediated cardiac metabolic reprogramming. Conclusions This study demonstrates that the 1–265 amino acid domain of CHK1 binds to the 157–400 domain of PKM2 and activates PKM2‐mediated metabolic reprogramming to promote cardiomyocyte proliferation and myocardial repair after ischemia/reperfusion injury in adult pigs.

Keywords